angiotensin ii, des-phe(8)- has been researched along with Genetic Predisposition in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragão, DS; Arita, DY; Bertoncello, N; Casarini, DE; Cunha, TS; Dantas, PS; Mattar-Rosa, R; Moreira, RP; Santos, R; Watanabe, IK; Yokota, R | 1 |
Chiong, M; Godoy, I; Jalil, JE; Lavandero, S; Ocaranza, MP; Palomera, C; Román, M | 1 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and Genetic Predisposition
Article | Year |
---|---|
Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
Topics: Angiotensin I; Animals; Blood Glucose; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Dosage; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Kidney; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrometry, Fluorescence | 2015 |
Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin-I-converting enzyme deletion/deletion genotype.
Topics: Adult; Angiotensin I; Angiotensin II; Antihypertensive Agents; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Vasoconstrictor Agents | 2003 |